Related Experiment Videos
[Total en-bloc spondylectomy for recurrence spinal tumor]
Keng Chen1, Lin Huang1, Zhaopeng Cai1
1Department of Orthopedics, Research Center of Spinal and Pelvic Tumor, Sun Yat-sen Memorial Hospital, Research Institute for Spinal Cord Injury of Sun Yat-sen University, Research Center of Spinal and Spinal Cord Disease, Guangzhou 510120, China.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]
|April 25, 2015
Summary
Total en-bloc spondylectomy (TES) is a viable option for select recurrent spinal tumors, showing improved neurological function and no recurrence in a small patient cohort. Careful patient selection is crucial for successful outcomes.
Area of Science:
- Spine surgery
- Oncology
- Orthopedics
Background:
- Recurrent spinal tumors pose significant treatment challenges.
- En-bloc resection offers potential for complete tumor removal.
- Total en-bloc spondylectomy (TES) is a complex surgical technique.
Purpose of the Study:
- To evaluate the clinical outcomes of TES for recurrent spinal tumors.
- To assess the safety and efficacy of TES in this patient population.
Main Methods:
- Retrospective study of 6 patients with recurrent spinal tumors undergoing TES.
- Procedures performed between January 2010 and October 2013.
- Evaluation of operative time, blood loss, neurological function, and complications.
Main Results:
- TES was performed on thoracic and lumbar spine tumors.
- Average follow-up was 23.2 months with no recurrence.
- Improved neurological function (ASIA grade) in 2 patients; no deterioration in others.
- Complications included pleural rupture, dural tear, and hemothorax; no perioperative deaths.
Conclusions:
- TES is a suitable option for carefully selected recurrent spinal tumors.
- The applicability of TES requires strict control and patient selection.
- TES can achieve favorable outcomes in recurrent spinal tumors.